from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1605/hisF

LFCtreatmentdescriptionclass of inhibitor

-0.129

Amikacinug/mL Amikacintranslation

-0.861

Cap5-10ug/mL Capreomycintranslation

-0.594

Rox10-50 ug/mL Roxithromycintranslation

0.243

SM2-5 ug/mL Streptomycintranslation

-0.928

Tet5-10 ug/mL Tetracyclinetranslation

-0.851

Rif0.2-5ug/mL Rifampicintranscription

-0.208

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.120

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.727

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.034

CPZ10-50 ug/mL Chlorpromazinerespiration

0.274

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.011

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.722

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.618

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.719

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.160

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.078

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.430

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.503

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.437

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.990

KCN5-20 ug/mL Potassium cyaniderespiration

0.306

NaN30.2-2 mM Sodium aziderespiration

0.313

Nigericin50 uM Nigericinrespiration

-0.368

TRC10-150 ug/mL Triclosanrespiration

0.313

TRZ10-25 ug/mL Thioridazinerespiration

0.255

Valinomycin0.5-10 uM Valinomycinrespiration

0.151

ZnSO42 mM ZnSO4respiration

0.315

menadione6-10 ug/mL Menadionerespiration

-0.126

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.444

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.477

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.154

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

0.107

Cephalexin20-100 ug/mL CephalexincellWall

-0.123

Cerulenin0.32-5 ug/mL CerulenincellWall

0.073

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.099

EMB10-20 ug/mL EthambutolcellWall

0.244

Eta12-40 ug/mL EthionamidecellWall

0.204

INH0.2-0.4 ug/mL IsoniazidcellWall

0.059

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.279

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.059

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.421

BZA0.12 mg/mL BenzamidearomaticAmides

-0.540

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.304

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.377

H2O24 mM hydrogen peroxideDNAdamaging

-0.607

Levo10 ug/mL LevofloxacinDNAdamaging

-0.731

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.947

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.273

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.311

UVUV-irradiationDNAdamaging

0.773

ARP41-4 ug/mL Antitubercular compound ARP4?

0.057

Antimycin12.5-50 ug/mL Antimycin A?

0.106

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.193

PA_110-50 ug/mL Antitubercular compound PA-1?

0.003

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.152

PA8240.2-2 ug/mL PA-824?

1.611

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.989

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.841

Verapamil50 uM Verapamil?

0.105

mercaptoethanol2 mM 2-Mercaptoethanol?

0.538

methoxatin10-20 ug/mL Methoxatin?